1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow GIST, Malignant: new trials by email Literature Review of GIST, Malignant trials Research Report on GIST, Malignant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| POETIG Trial - POnatinib After rEsisTance to Imatinib in GIST Ponatinib 30 MG - GIST, Malignant, KIT Exon 13 Mutation | Phase 2 | Unknown | Sebastian Bauer | 81 | 2017-03-22 | 2017-05-31 |
Gastrointestinal Stromal Tumors (1)
Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Connective Tissue (1) · Neoplasms, Connective and Soft Tissue (1)
ponatinib (1)
Sebastian Bauer (1)
Germany (1)
Sebastian Bauer, Prof. Dr. (1)